Business Wire

Absorb Software Displays Its Commitment to Customer Data Security with Successful SOC 2 Examination

CALGARY, Alberta--(BUSINESS WIRE)--Absorb Software, maker of Absorb Learning Management System (LMS) has successfully completed its AICPA System and Organization Controls (SOC) 2 Type 2 examination ...
TCTMD

ABSORB II: Absorb BVS, Xience Yield Similar Outcomes at 2 Years

At 2 years, there are no significant differences with regard to clinical outcomes between the Absorb everolimus-eluting bioresorbable scaffold and the Xience everolimus-eluting stent, according to ...
TCTMD

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

WASHINGTON, DC—Two-year results from the ABSORB III study presented today at the American College of Cardiology 2017 Scientific Session show that the Absorb GT1 bioresorbable vascular scaffold (BVS, ...
Healio

ABSORB II: Bioresorbable scaffold outcomes comparable to DES at 1 year

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio WASHINGTON — The Absorb bioresorbable ...
Medscape

ABSORB-3 at 2 Years: More CV Events With Absorb BVS vs Xience

WASHINGTON, DC — Patients who received the Absorb (Abbott Vascular) bioresorbable vascular scaffold (BVS) in the ABSORB-3 trial showed a primary outcome, counting only events occurring between the ...
Medscape

Negative Data Piling Up on Absorb Bioresorbable Scaffold

AMSTERDAM, NL — Consistent with prior trials, the risk of scaffold thrombosis was significantly higher in patients receiving the Absorb (Abbott Vascular) bioresorbable vascular scaffold (BVS) than an ...
Healio

ABSORB Japan: BVS, EES yield similar vessel healing at 2 years

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio At 2 years after implantation, a fully ...